Hays RD, Shapiro MF. An overview of generic health related quality-of-life measures for HIV research. Qual Life Res 1992; 1: 91–97.
Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res. 1992; 1: 359–366.
Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument Ann Intern Med 1992;
Schag CA, Ganz PA, Kahn B, Petersen L. Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-evaluation System (HOPES). Qual Life Res 1992; 1: 397–413.
Ganz PA, Coscarelli Schag CA, Kahn B, Petersen L, Hirji K. Describing the health-related quality of life impact of HIV infection: findings from a study using the HIV Overview of Problems-evaluation System (HOPES). Qual Life Res 1993; 2: 109–119.
Hays RD, Wu AW, Cleary PD, et al. Associations of time tradeoff with health-related quality of life profile measures in HIV disease (abstract). AHSR FHSR Ann Meet Abstr Book 1996; 13: 93–94.
Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. Med Care 1995; 33: AS15–AS25.
Wu AW, Coleson LC, Holbrook J, Jabs DA. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. Arch Ophthalmol 1996; 114: 841–847.
Copfer AE, Ampel NM, Hughes TE et al. The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison. Qual Life Res 1996; 5: 281–286.
Revicki DA, Simpson KN, Wu AW, LaVallee RL. Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques. Qual Life Res 1995; 4: 309–318.
Kaplan RM. An outcomes-based model for directing decisions in women's health care. Clin Obstet Gynecol 1994; 37(1): 192–206.
Berzon R, Patrick D, Guyatt G, Conley JM. Intellectual property considerations in the development and use of HRQL measures for clinical trial research. Qual Life Res 1994; 3: 273–277.
Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993; 2: 477–487.
Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1339–1341.
Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Kaplan RM, McCutchan JA, Navarro AM Anderson JP. Quality adjusted survival analysis: a neglected application of the Quality of Well-being scale. Psychol Health: Int J 1994; 9: 131–141.
Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Service Res 1976; 11(4): 478–507.
Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Service Res 1988; 23: 203–234.
Kaplan RM, Anderson JP. The Quality of Well-being scale: rationale for a single quality of life index. In: Walker S, Walker R, Rosser R, eds. quality of life Assessment and Application. London: MTP Press, 1988: 51–77.
Kaplan RM, Bush JW Berry CC. Health Status Index: category rating versus magnitude estimation for measuring levels of well-being. Med Care 1979; 17(5): 501–525.
Kaplan RM. Human preference measurement for health decisions and the evaluation of of long-term care. In: Kane R, Kane L, Kane RA, eds. Values and Long-Term Care. Lexington, MA: Lexington Books, 1982: 157–188.
Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev 1993; 19 (Suppl A): 85–96.
Erickson P, Kendall EA, Anderson JP, Kaplan RM. Using composite health status measures to assess the nation's health. Med Care 1989; 27 Suppl 3: S66–S76.
McHorney CA. Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey. Gerontologist 1996; 36: 571–583.
McHorney CA, Kosinski M, Ware JEJ. Comparisons of the_ costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care 1994; 32: 551–567.
Anderson JP, Bush JW, Berry CC. Internal consistency analysis: a method for studying the accuracy of function assessment for health outcome and quality of life evaluation. J Clin Epidemiol 1988; 41: 127–137.
Anderson JP, Bush JW, Berry CC. Classifying function for health outcome and quality-of-life evaluation. Self versus interviewer modes. Med Care 1986; 24: 454–469.
Anderson JP, Kaplan RM, Berry CC, Bush JW, Rumbaut RG. Interday reliability of function assessment for a health status measure. The Quality of Well-being scale. Med Care 1989; 27: 1076–1083.
Tarlov AR, Ware JEJ, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925–930.
Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, Greenfield S. Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study. J Clin Epidemiol 1994; 47: 719–730.
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): conceptual framework and items selection. Med Care 1992; 30: 473–483.
Wu AW, Rubin HR, Mathews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. J AIDS 1993; 6(5): 452–458.
Burgess A, Dayer M, Catalan J, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health related quality-of-life measures: a preliminary analysis. AIDS 1993; 7(7): 1001–1008.
Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J AIDS Human Retrovirol 1995; 8(3): 253–265.
Heaton RK, Kirson D, Velin RA, Grant I. Utility of clinical ratings for detecting cognitive change in HIV infection. In: Grant I, Martin A, eds. Neuorpsychology of HIV Infection. Oxford Universtiy Press, 1994: 188–206.
Gullivich SJ, Kalmijn JA, Thal LJ et al. Sensory testing in HIV-I infected men. Arch Neurol 1992; 49: 1281–1284.
Hamilton MA. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–196.
Beck AT. Cognitive Therapy and the Emotional Disorders. New York: Hoeber, 1976.
Heaton RK, Marcotte TV, White DA, et al. Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clin Neuropsychol 1996; 10(1): 1–14.
Kerner DN, Grant I, Atkinson JH, Hesselink J, McCutchan, A, Kaplan RM. Psychosocial and biological predictors of mortality in HIV-infected adults. Ann Behav Med 1996.
Rubin HC, Patterson TL, Atkinson JH et al. Tracking effects of depression on life quality in HIV. In: Second International Conference on AIDS Impact, Brighton UK, 7–10 July 1994.
Kaplan RM, Anderson JP, Patterson T. Validity of the Quality of Well-being scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosomat Med 1995; 57(2): 138–147.